π Lecture 35 β BASIC NEUROCHEMISTRY
π Overview: This lecture continues the discussion on the involvement of serotonin (5HT) in the modulation of various behaviors, and then provides a comprehensive overview of Acetylcholine (ACh), its synthesis, receptors, and the drugs that affect cholinergic synapses. Understanding these neurotransmitter systems is critical for grasping the neurochemical basis of behavior, neurological disorders, and psychopharmacology.
ποΈ Topics Covered
The lecture covers the regulation of behaviors by serotonin, including temperature regulation, sensory perception, sleep, depression, and sexual behaviors. It then transitions to a detailed exploration of Acetylcholine, beginning with its discovery and classification. The synthesis and breakdown of ACh are explained, followed by its neuroanatomical sites of involvement. Finally, the lecture details the specific drugs and toxins that act as agonists and antagonists at cholinergic synapses, including their mechanisms and clinical applications.
π Lecture Summary
5HT and Behaviors
This section details the specific behaviors modulated by serotonin (5HT), building upon previous discussions of the serotonergic system. Each behavior is linked to experimental evidence showing how manipulating 5HT levels alters the outcome.
-
Temperature regulation: This is an important motivational behavior dependent on day and night cycles. If 5HT is injected intraventricularly, it leads to increased body temperature. When PCPA is injected to deplete brain serotonin, and then raphe nuclei are electrically stimulated, no rise in body temperature takes place. The body temperature would otherwise rise with the stimulation of raphe nuclei, as increased serotonin leads to increased body temperature.
-
Sensory perception: 5HT is involved in producing the heightened sensory and visuomotor hallucinogenic effect of LSD. Injections of PCPA (which depletes brain serotonin) reduced motor activity and emotional reactivity but increased sensitivity to pain. This means in rats, the electrical current given for a response is much lower; they respond at a lower current with avoidance and other behaviors. Further, when 5HT levels are decreased, this slows down the process of tolerance to morphine (tolerance means that the effectiveness of a drug dosage is lessened, so the dosage has to be increased to have the same effect or response).
-
Serotonin and sleep: Evidence for the involvement of 5HT in sleep is provided by experiments in which levels of 5HT are increased by administration of MAOI (reduced deactivation) or 5HTP (increased enzymes) or 5HT itself. This treatment leads to an increase in levels of 5HT and also increases time spent in Slow Wave Sleep (SWS) . If 5HT is decreased, then the time spent in SWS is also decreased. PCPA administration (which depletes/reduces 5HT drastically) also leads to reduced Rapid Eye Movement sleep (REM) .
Jouvet (1973) was the first to identify the relationship between 5HT and sleep. Jouvet carried out experiments manipulating raphe nuclei and seeing its effect in cats (cats are best for sleep research as they spend 2/3 of their life in sleep). The electrolytic lesion of the raphe nuclei led to decreased 5HT and decreased time spent in sleep. When 5HT was reduced by 85%, time in sleep was reduced to 20% (insomniac cats!). Further, when PCPA was injected, 1-2 days after injection (when complete depletion of brain 5HT has taken place), increased insomnia followed. This was confirmed because injections of 5HTP (which increases 5HT and reverses PCPA-induced lower levels of 5HT) reversed the insomnia induced by PCPA.
- Other behaviours: 5HT appears to be involved in depression, as there is evidence of decreased 5HT and 5HIAA (the 5HT metabolite) in brains of suicide victims (Bourne et al., 1968). This indicates that in depression, 5HT is lower than normal levels (antidepressants such as tricyclics and MAOIs also act to increase levels of 5HT). Decreases in 5HT lead to a disinhibition of behaviors (reduced controls on behaviors), increased impulsivity, increased aggressiveness, and increased suicidal tendencies. Serotonin is also involved in the control of sexual and reproductive behaviors. PCPA, which depletes 5HT, increased sex drive in males. In females, the ovulation cycle is blocked by narcotics; this blockade is removed by administration of 5HT.
π‘ Why this matters: This section demonstrates that 5HT is not a simple "happy" chemical but a major neurotransmitter influencing a wide range of motivational and other behaviors, from basic homeostasis (temperature) to complex states like depression and aggression.
Acetylcholine: ACh
This section introduces ACh as one of the major neurotransmitters, distinct as a class by itself. Its effects have been studied since the 1920s via bioassay and neuromuscular transmission, demonstrated by frog muscle contraction when ACh is applied. ACh is used by neurons which terminate on the neuromuscular junction.
This is classified as an excitatory NT, as Excitatory Post Synaptic Potentials are released in the muscle cell. However, ACh has an excitatory effect on skeletal muscles but is inhibitory at the heart. The location is as important as the classification of the NT for its actions as excitatory or inhibitory. ACh is also found to play an active role in brain areas such as the hypothalamus and cerebral cortex. It is involved in learning and memory (known as the memory molecule) and Rapid Eye Movement sleep.
The study of ACh is easier than other neurotransmitters as it is easy to remove and study outside the brain in a petri dish. The nicotinic receptor was the first receptor identified. Acetylcholine is found in ganglions of the autonomic nervous system and the target organs of the parasympathetic nervous system.
ACh has two distinctive types of receptors:
- Nicotinic: Connects the muscle fibers and works through sodium channels (these are ionotropic receptors). Curare, a poison, can block the transmission of ACh at neuromuscular joints. In neuromuscular joints, nicotine mimics the excitatory effects of ACh.
- Muscarinic: Found in the CNS and these use G proteins and cyclic AMPs as second messengers. These are classified as metabotropic receptors. Atropine blocks these receptors, leading to loss of memory.
π Definition β Cholinergic receptors: The receptors for acetylcholine.
Synthesis
Acetylcholine is synthesized in a catalytic action of cholinesterase on Co-enzyme A + its acetate ion and Choline. It acts to detach the acetate ion from co-enzyme A and attach it with choline to form acetylcholine and separate the Co Enzyme A. The Co Enzyme A is found in Vitamin B, and choline is broken down from lipids. Choline is the rate-limiting factor of ACh (no choline, no ACh). The ACh is further broken down by the enzyme Choline acetyl transferase, whereby ACh is broken down into choline and acetyl via a process of hydrolysis. Half of the choline in this chemical action is retrieved and recycled.
Involvement and neuroanatomical sites of ACh
ACh is formed in the cell bodies of the neuron and transported to the neuromuscular junctions. It is released by action potential, crosses over, and activates the muscle fiber.
I. Locations of ACh:
- Found at all neuromuscular junctions, autonomic ganglion, and parasympathetic systems.
- Hippocampus receives ACh input from the medial septal nucleus.
- ACh projects into the ascending reticular arousal system.
- Involved in auditory and visual systems.
- Found in the caudate nucleus.
- Found in the ventral basal hypothalamus.
- In the supraoptic nucleus of the brain stem.
- ACh acts as a sensory transmitter in thermal receptors. Pain is produced by directly putting ACh onto a blister on the skin.
II. Functional Roles of ACh:
- Involved in the release of catecholamines (works to balance other NTs and has interaction with DA, NE, and 5HT in all functions).
- Conduction of signals: it acts in axonal conduction by depolarizing the axon.
Steps in ACh synthesis where drugs can modulate action
This section details the specific drugs affecting cholinergic synapses at each step of neurotransmission.
Step 1: Synthesis: ACh synthesis can be blocked by styryl pyridine, a derivative.
Step 2: Release of ACh from the presynaptic membrane is enhanced by Ξ²-bungarotoxin and black widow spider venom and blocked by botulinus toxin (a deadly food poison). The latter acts to block ACh transmission, leading to total paralysis.
Step 3: Post receptor sites can be activated or blocked in both types of receptors. These are activated by Ach agonists or cholinomimetic drugs and anticholinesterases (blocking the enzyme which breaks down ACh).
- Nicotinic receptors are blocked by Ξ±-Bungarotoxin and Curare (Tubocurarine). Local anesthetics and drugs such as phencyclidine bind to these receptors to modulate action. Curare, a poison used by South American Indians in arrows, prevents ACh from reaching the post-receptor area (occupies the sites). Since the muscles do not get activated, this leads to blockade of all muscular responses. Since there is no post-synaptic response, no nerve command is processed, leading to total paralysis of muscles. Poison from cobra, alpha bungarotoxin, acts through this mechanism.
- Muscarinic receptors are blocked by atropine (belladonna) and scopolamine.
Step 4: Presynaptic receptor blockade: Atropine and scopolamine block these.
Step 5: Inhibition of inactivation activity leads to an increase in ACh in the brain by physostigmine, which blocks acetylcholinesterase from breaking down ACh. This leads to increased levels of ACh in the system, resulting in repeated stimulation of muscles, meaning the muscles would be repeatedly stimulated, resulting in violent muscular contractions. It is reported that there is a West Indian tribal custom where Calabar bean extract is used to find if a person is guilty or innocent. If guilty, the person who had taken the bean extract as a test would die; if they were innocent, the person would swallow and vomit.
Physostigmine is used as a therapy for Myasthenia Gravis: a neurological disorder where the muscles are extremely weak and do not have normal levels of ACh for muscles to act. The drugs given increase ACh (cholinomimetics, or anticholinesterases). Increases in ACh using this therapy can lead to nightmares, confusion, and hallucination.
Receptor Agonists:
- Muscarinic receptors: Affected by muscarinic agonists, one of which is the muscarinic extract from poison mushrooms. If taken, it increases ACh activity, leading to increased sweating, increased salivation, constriction of pupils, and decreased heart rate. Also muscarine, which mimics the inhibitory effects of ACh.
- Nicotinic receptor agonists: In neuromuscular joints, nicotine mimics the excitatory effects of ACh. Nicotinic agonists could be useful in the treatment of a variety of neurological disorders including Alzheimer's disease, Parkinson's disease, and chronic pain.
Receptor Antagonists:
- Muscarinic receptors: Atropine is an antagonist. Atropine Belladonna (night shade poison) blocks muscarinic receptors, acting as a false transmitter. It occupies the post-receptor sites and does not transmit the message forward. Atropine belladonna liquid leads to dilation of pupils when applied directly onto the eyes (Belladonna means "beautiful woman" because women used to apply it to their eyelids for a wider eye look). From Grecian times, Hippocrates used it for stomach ailments and cosmetics. Atropine and scopolamine lead to decreased ACh in the brain, leading to amnesia (reduced ACh in the Alzheimer brain is related to their memory loss). This also indicates that ACh is involved in learning and memory.
- Muscarinic antagonists are used to control and prevent vomiting and are also useful for the treatment of Parkinson's disease. In large doses, however, the muscarinic antagonists cause severe side effects such as hallucinations and memory disturbances.
Step 6: Choline uptake: This step is affected by Ξ²-Bungarotoxin and black spider widow venom.
The lecture concludes with a reference to Table 1, which summarizes the natural cholinergic agonists and antagonists.
β Key Takeaways
The most critical points from this lecture are the specific behavioral roles of serotonin (5HT), from temperature regulation and sleep to depression and aggression, and the detailed pharmacology of the cholinergic system. For 5HT, remember that depleting it with PCPA reduces sleep, increases pain sensitivity, and disinhibits behavior, while increasing it has the opposite effects. For ACh, understand that it is the key neurotransmitter at the neuromuscular junction and is known as the "memory molecule." You must know the difference between nicotinic (ionotropic, blocked by curare) and muscarinic (metabotropic, blocked by atropine) receptors. Finally, memorize the "trophy" examples of drugs and toxins that affect each step of cholinergic transmission: botulinus toxin blocks release, physostigmine blocks breakdown (used for Myasthenia Gravis), and atropine is an antagonist at muscarinic receptors.
π§ Quick Revision Questions
- What is the effect of injecting PCPA on body temperature when the raphe nuclei are electrically stimulated, and why?
- How did Jouvet (1973) experimentally demonstrate the relationship between serotonin and sleep in cats?
- Name the two main types of receptors for Acetylcholine, and give one key difference in their mechanism of action (ionotropic vs. metabotropic).
- What is the therapeutic use of physostigmine, and what is its mechanism of action at the cholinergic synapse?
- Which drug blocks muscarinic receptors, and what is the effect of this blockade on memory?
π Lecture 36 β Basic Neurochemistry
π Overview: This lecture continues the exploration of neurotransmitters by examining acetylcholine (ACh) in detail, including its role in arousal, drinking, aggression, punishment, and Alzheimer's disease. It then expands to cover other major neurotransmitters, including glutamic acid, GABA, glycine, peptides such as brain opioids, and psychotogenic compounds, concluding with an introduction to psychopharmacology.
ποΈ Topics Covered
The lecture covers major neurotransmitters and their behavioral modulation, beginning with ACh's roles in arousal, drinking behavior, sham rage, punishment systems, and Alzheimer's disease pathology and treatment. It then addresses other neurotransmitters including glutamic acid, GABA (with its synthesis, distribution, and pharmacological agents), glycine, and peptides such as brain opioids. The lecture concludes with discussion of psychotogenic compounds like LSD and mescaline, and an introduction to psychopharmacology as a field.
π Lecture Summary
Major Neurotransmitter: Acetylcholine (continued)
Acetylcholine (ACh) has a unique and important neurotransmitter role in the brain. Without normal levels of ACh and its receptors working effectively, the brain would not be able to command the muscles of the body.
π Definition β ACh: A neurotransmitter critical for muscle control, arousal, and various behavioral functions throughout the brain.
-
Arousal: ACh has an important role as an excitant of neural activity. Brain electrical activity is aroused and can be monitored by Electroencephalographic (EEG) recordings. When ACh is injected intravenously or applied to the cortex, it leads to increased EEG activity. When anticholinergics are administered, they block and reduce ACh levels in the brain, and EEG arousal is also blocked. Interestingly, this does not affect behavioral arousal. ACh is involved in sleeping and awakening via the locus coeruleus, which may explain the involvement of ACh in brain electrical activity arousal.
-
Drinking: ACh is important in drinking and fluid regulation. The regulation of water intake takes place via the ACh mechanism. Cellular dehydration is mediated by the cholinoceptive system of neurons in the preoptic area of the hypothalamus. They monitor the extracellular space for volumetric changes (changes in the volume of fluid) produced after changes in isotonic body fluids. Whenever the intracellular membrane runs short of fluid, it takes in fluids from the extracellular membrane. This leads to the release of Renin from kidneys, which leads to increased formation of Angiotensin, which then stimulates the neurons in the preoptic area. This communication goes from the brain to the kidneys and back, leading to an increase in fluid and salt intake.
-
Sham rage and attack: Sham rage is the physical appearance of rage without an object of rage in front of the animal (cats and rats). In cats, rage appears as hissing, spitting, and raised hair on the dorsal surface of the body and the tail. Sham rage is induced in cats and rats by cholinergic stimulation of the amygdala and septum. Aggression is also produced by the midbrain ventral tegmental area. Further, the killing attack pathways in rats (of mice) and cats (of rats) are cholinergically organized. Cholinergic stimulation of the amygdala, lateral hypothalamus (LH), and midbrain tegmental regions leads to a quiet biting attack in rats and cats. This attack is blocked by atropine.
-
Punishment: Reinforcing stimuli increase the probability of a response, whereas punishing stimuli decrease the probability of a response. Intracranial self-stimulation is part of the reward systems and is reinforcing, so an animal would keep self-stimulating for its own reward. On the other hand, the periventricular area in the hypothalamus is part of punishment systems. The ventromedial hypothalamus (VMH) is part of this punishment system. Rats previously trained for Variable Interval Schedule (VIS) for food are run in an experiment where every response is followed by a shock. (VIS is when the time between reinforcement varies.) When every response is followed by a shock, a reduction in VIS response follows. If we lesion the Ventromedial nuclei (VMN), it leads to an increase in the response which had been depressed (leads to disinhibition). Anti-ACh does the sameβthey lead to an increase in disinhibition of the punished response. Inhibition of punished response means the animal would stop responding, but disinhibition means the response would return as the inhibitor has been blocked. Anti-ACh are involved in removing the inhibition.
-
Alzheimer's: Alzheimer's is a disease of old age where degeneration of the brain takes place to the point where the person cannot carry out any function. The important feature of this disease is loss of memory. Recently, muscarinic receptor agonists have been used in the treatment of Alzheimer's disease. This replaces depleted ACh in the basal forebrain as the neurons in this area degenerate. Another treatment is administration of acetylcholinesterase inhibitors, which increases levels of ACh in the synapse as the breakdown is blocked, thereby increasing cholinergic activity in damaged brain areas. Physostigmine was used earlier but results indicated strong side effects. Tetrahydroaminoacridine (THA, or tacrine) was the first cholinesterase inhibitor approved for Alzheimer's patients. Patients given THA showed some reduction of Alzheimer's symptoms and were able to resume normal activity. However, not all patients can use it as it has strong side effects on increasing liver enzymes.
π‘ Why this matters: ACh is also involved in learning, memory, motor behaviors (working in balance with dopamine for Parkinson's and other motor disorders), pain, and coordination with brain opioids.
Other NT's
In addition to the neurotransmitters already discussedβthe catecholamines, indolamine, and acetylcholineβthere are other neurotransmitters active within the CNS.
-
Glutamic acid: Glutamate and GABA are found in simple organisms. The first neurotransmitter to evolve in the brain is Glutamate. Glutamate is an excitatory neurotransmitter, and its receptors are found all over the brain. Chinese food contains a large amount of Monosodium Glutamate. There are three types of receptors: NMDA, quisqualate, and kainate receptors. These receptors are all important in working with other NTs.
-
GABA (Gamma Aminobutyric acid): GABA was first synthesized in 1883 and known to be a metabolite of plant and microbial metabolism. It was discovered in the mammalian brain in the 1950's, found in very high concentrations in the brain and spinal cord. In the brain, GABA is found in amounts 10-15 times greater than dopamine (DA), norepinephrine (NE), or serotonin (5HT); a minuscule amount is also found in the retina. It is generally classified as an inhibitory NT and accounts, along with other amino acids, for a major part of neuronal transmission. GABA works to balance the monoamines DA, NA, and 5HT wherever they are involved. GABA is implicated directly in Huntington's chorea, which is due to degeneration of GABAminergic neurons. GABA is indirectly involved in Parkinson's, epilepsy (abnormality in the biochemistry of GABAminergic neurons), and schizophrenia.
GABA Synthesis: This involves only two steps: one to synthesize it and one to break it down:
- Synthesis: One-step synthesis from its amino acid precursor Glutamic Acid, which is decarboxylated by the enzyme Glutamic acid decarboxylase (GAD).
π Formula: Glutamic acid β GABA (catalyzed by glutamic acid decarboxylase and coenzyme pyroxidal phosphate; this process can be blocked by ions such as chloride and zinc)
- Catabolism: GABA is trans-aminated by GABA-A-oxoglutarate transaminase. GABA is transformed into Succinic Acid Semialdehyde to return back into the Krebs cycle. In the transaminase process, GABA conversion is reversed to glutamic acid through alpha-ketoglutarate, which acts as an amine acceptor.
Distribution and pharmacological agents: From monkey to human brain (1968-1971 studies), the highest GABAminergic concentrations were found in the Substantia Nigra (SN), Globus Pallidus (GP), and the Hypothalamus (hyp).
Agonists: The post-receptor GABA agonist is muscimol. This leads to increased arousal, self-mutilation, and increased feeding if placed in the hypothalamus (disinhibition of inhibition).
Antagonists: Post-receptor antagonists or receptor blockade by picrotoxin and bicuculine. Benzodiazepines (Valium and Librium) stimulate a particular site of GABAminergic neurons. This alleviates anxiety symptoms/response.
Glycine
Glycine is another inhibitory neurotransmitter like GABA; however, research is still ongoing to identify its role. It is found in the mammalian spinal cord and brain. It is found in greater amounts in the spinal grey matter than the brain, suggesting it may be working with interneurons. However, no distinct and clear glycine pathways exist in the brain.
π Definition β Strychnine: A poison that blocks the action of glycine and also blocks postsynaptic inhibition.
PEPTIDES
Neuroactive peptides are candidates for neurotransmitters. Some of these are like orthodox NTs, some are performing modulatory or regulatory roles, and some also act as neurohormones.
Key peptides include: Brain opioids, Angiotensin II (thirst), Oxytocin and Vasopressin, Luteinizing Hormone Releasing Hormone (LH-RH), Substance P, and Adreno-Corticotropic Hormone (ACTH).
Brain Opioids
Endorphins (large molecules) and Enkephalins (smaller molecules).
Hughes and Kosterlitz (1975) in Aberdeen discovered the existence of brain opioids in the brain. This was a landmark finding because for the first time, it was found that this chemical compound was similar in composition to the opiates morphine, heroin, etc. In later research, Huda Akil and her research group reported the highest concentration in Substantia Nigra, lateral hypothalamus, cerebral cortex, and periaqueductal gray.
Extracts taken from the brain, when administered to laboratory animals, led to analgesia, wet dog shakes upon application (in a manner similar to administration of opiates). Similarly, akinesia, hypothermia, rigidity, and catalepsy were also seen.
π Question: Are brain opioids natural neuroleptics (antipsychotic drugs)?
In some cases, psychotic patients who are not responding to other treatment drugs (neuroleptics) have responded to short-term endorphin treatment (McGreer and McGreer, 1980). Brain opioids are also involved in emotions, growth, pleasure (acting through the mesolimbic DA pathways), stress-induced analgesia (Akil et al., 1975), growth, and development (Najam and Panksepp, 1980).
Opioid antagonists have also been found effective in the treatment of autism and childhood disorders. Panksepp et al.'s theory of brain opioids and attachment states that brain opiates are natural comforters in the brain; it is when they are blocked that addicts turn to morphine/heroin, and autistic children have higher than normal brain opiate levels. The discovery that pain and acupuncture pathways are similar to brain opioid pathways in the body and spinal cord provides strong evidence for the involvement of brain opiates in pain and acupuncture.
Narcotic analgesics such as morphine and heroin are severely addictive, have high tolerance value, are potent analgesics, potent anticongestants, and are also used for stomach and digestive problems. The interesting aspect of opiates' effect on pain is that it is only the affective component which is reduced (one does not feel the pain); the physical component is still there. Pain is still there, but the patients do not care about itβthe reaction to pain is diminished.
Psychotogenic Compounds
Hallucinogens:
-
LSD (Lysergic acid diethylamide): A potent drugβa small dose of 1/10,000 gram is effective. It has great tolerance to the point that the same dose is not effective if taken a second time, meaning an increased dosage is needed every time for an effect to take place. The LSD "trip" depends on the mood and personality of the user and can be controlled.
-
Mescaline: A hallucinogenic compound made from plant extracts in Mexico. It is used in religious ceremonies by tribes in Mexico.
Psychopharmacology
This area of specialization is the study of the effects of drugs on psychological processes. It is both a basic and an applied science. "A recognition of the interrelationships between pharmacological agents, neuroregulators, and behavior has become essential for those involved in helping individuals who have psychiatric disorders." Therefore, to develop drugs, research in the laboratory is needed before the drugs can be tested and usedβespecially on humans.
The evidence is provided when the symptoms of a psychiatric disorder are removed when linked to a neurotransmitter, and then the normalization of behavior should occur with normalization of levels of NT in the brain. Further, known effective exogenous substances should have similar chemical effects as the endogenous (brain) chemicals. Pharmacological substances should be able to interact with NTs at given sites if they have the same chemical composition.
β Key Takeaways
Students must remember that ACh plays critical roles in arousal, drinking, aggression, punishment systems, and Alzheimer's disease, with treatments involving muscarinic agonists and acetylcholinesterase inhibitors like THA (tacrine). GABA is the primary inhibitory neurotransmitter synthesized from glutamic acid via GAD, is found in highest concentrations in the substantia nigra, globus pallidus, and hypothalamus, and is modulated by benzodiazepines. Brain opioids (endorphins and enkephalins) are natural compounds that reduce the affective component of pain and are involved in pleasure, stress-induced analgesia, and attachment behavior. Hallucinogens like LSD and mescaline produce altered states of consciousness with high tolerance development. Psychopharmacology studies drug effects on psychological processes and relies on the principle that effective drugs should interact with specific neurotransmitter systems to normalize behavior.
π§ Quick Revision Questions
- What is the role of ACh in drinking behavior, and what is the chain of events from cellular dehydration to increased fluid intake?
- How does anti-ACh produce disinhibition of punished responses, and what brain structure is involved in the punishment system?
- What are the two steps in GABA synthesis and breakdown, and what enzyme catalyzes the conversion of glutamic acid to GABA?
- What is the difference between endorphins and enkephalins, and how do brain opioids affect the experience of pain?
- What evidence supports the use of opioid antagonists in treating autism, and what is Panksepp's theory linking brain opioids to attachment?
π Lecture 37 β Brain and Motivational States
π Overview: This lecture explores the neurological foundations of motivational states, focusing on homeostasis as the underlying principle that drives behavior. It details how biological systems like temperature regulation are managed by the brain through feedback and feedforward mechanisms. Understanding these processes is crucial for grasping how organisms maintain internal stability for survival and how disruptions can lead to pathology.
ποΈ Topics Covered
The lecture introduces the concept of homeostasis as a fundamental biological system maintained by neurological feedback. It details the brainβs modulation of temperature regulation, distinguishing between ectotherms and endotherms. The role of the hypothalamus as a master control center is emphasized, including its set point mechanism and the biochemical influences of endorphins. The lecture concludes with an explanation of fever as a pathological alteration of this set point.
π Lecture Summary
Objectives
This lecture aims to familiarize students with the process of homeostasis and the biological systems involved, the brain modulation of these systems, and how the bodyβs systems compete for survival. It specifically covers brain and motivational states, homeostasis (including temperature regulation, hunger, thirst, bio-rhythms, sleep, and awakening), pathology related to sleep cycles, and sleep disorders and treatment.
Homeostasis:
Homeostasis is the balance and optimal functioning system of the body that must be maintained for the survival of the organism. Well-defined, autonomous neurological feedback systems work to maintain an internally stable environment. These include feedforward and feedback systems that constantly monitor and inform the brain and organs of each otherβs status. For example, somatosensory systems (skin sensors) send temperature information to receptors in the brain, which send messages for adjustments. Receptors exist both outside and within the brain. βIt is only against a homeostatic background that other more active systems can function, and many of an animalβs activities are motivated by the homeostatic needs,β (Bridgeman 1988, p 237). Homeostasis evolved to support survival, and if any problems arise, the whole system needs readjustments. Minor issues are sustained and corrected, but major, unmanaged changes can lead to death. Actions and behaviors are motivated by these homeostatic signals of the bodyβs needs. There are internal receptors, external stimuli, brain mechanisms, and neurochemical regulatory systems, all well-synchronized. Receptors evolved for specialized functions like temperature regulation, hunger, thirst, and sleep.
Temperature Regulation
Temperature regulation is a motivated behavior with all its key characteristics: it is purposive (goal to warm or cool), persistent (behavior continues until the goal is reached), has periodicity (e.g., winter nest building), and is prioritized. This is a well-defined system with a clear evolutionary path for maintaining optimum body functioning. The development of a strong and sensitive thermoregulatory system was necessary for survival as species evolved in diverse environments.
π Definition β Ectotherms: Amphibians and reptiles that depend on their external environment for temperature regulation. They are βsolar powered,β adjusting by relocating to warmer or cooler places. They have evolved vasoconstrictors and vasodilators on the skin. This response is directly controlled by thermoregulatory receptors in the hypothalamus and brain.
π Definition β Endotherms: Mammals and birds that have evolved an effective internal temperature control system with a set point, functioning like a thermostat. This allows for sustained activity for longer periods compared to ectotherms. They can also make environmental adjustments (e.g., seeking shade, building shelters).
π Definition β Set point: An internal standard (e.g., temperature) that the body functions to maintain by cooling or heating through homeostasis. There is a neutral zone range around the set point within which temperature can vary slightly. If temperature goes beyond this range, thermoregulatory mechanisms are activated. Endotherms also make environmental adjustments: (a) to cool the body (e.g., perspiration, seeking shade) and (b) to heat the body (e.g., shelter, fire, huddling). π Formula/Mechanism: Heat production is achieved by increasing basal metabolism, muscular activity, shivering, and sympathetic system activity. Heat loss is achieved by evaporation (sweating) and conduction (e.g., bathing). Response to cold is vasoconstriction of peripheral blood vessels, and piloerection in fur-bearing animals.
π Definition β Brain/neural substrates of thermoregulatory behavior: The preoptic area of the anterior hypothalamus is the master control for both heating and cooling. Heating this area leads to sweating; cooling it leads to shivering. Lower phylogenetic areas in the brain stem and spinal cord are under hypothalamic control but have a wider neutral zone, making them less refined and potentially dangerous. The biochemical control is with endorphins (brain opioids); injecting them into the hypothalamus lowers body temperature, an effect blocked by naloxone (an opiate antagonist) because pain and temperature sensory systems are related. π Example: In a laboratory experiment, lizards (ectotherms) were anesthetized by being kept in ice for surgery; they would return to a normal state when warmed.
What happens in fever?
Fever occurs when bacteria or viruses produce pyrogens which affect the hypothalamic set point. The set point rises (e.g., from 98.4Β°F to 101Β°F), but the body is still at 98.4Β°F. Signals are sent to heat up the body: shivering, cold hands and feet, faster metabolism. When an antipyretic like aspirin is taken, the set point is reduced back to 98.4Β°F. Now the body, which has been at 101Β°F, needs cooling. This leads to sweating and taking off blanketsβthe fever βbreaks.β In humans, clothes and houses act as thermoregulatory devices. π‘ Why this matters: This explains the physiological and behavioral experience of having a fever and the effect of medication.
β Key Takeaways
Homeostasis is the foundational principle for all motivated behaviors, maintained by sophisticated neurological feedback systems. The hypothalamus, particularly the preoptic area, is the master regulator of temperature, setting a specific set point and managing heat production and loss. Ectotherms rely on external environments, while endotherms have internal controls that allow for sustained activity. Fever is a clear example of a pathological state where pyrogens alter the hypothalamic set point, and antipyretics work by resetting it, causing the sensation of fever βbreaking.β
π§ Quick Revision Questions
- Define homeostasis and explain its role in motivating behavior.
- Differentiate between ectotherms and endotherms in terms of temperature regulation.
- What is the role of the preoptic area of the anterior hypothalamus in thermoregulation?
- Describe the sequence of events in the body when the hypothalamic set point is raised by pyrogens (fever).
- How does aspirin (an antipyretic) affect the bodyβs thermoregulatory response during a fever?
π Lecture 38 β Brain and Motivational States
π Overview: This lecture explores the biological foundations of motivation, focusing on how the brain regulates fundamental survival behaviors. It covers biological rhythms, circadian cycles, body temperature regulation, and the neural and physiological mechanisms controlling hunger and feeding behavior. Understanding these systems is crucial for comprehending how internal states drive behavior and how disruptions can lead to disorders like obesity, sleep disorders, and seasonal affective disorder.
ποΈ Topics Covered
This lecture covers biological rhythms and their characteristics (period, frequency, amplitude, phase), circadian rhythms controlled by the suprachiasmatic nucleus (SCN), body temperature cycles tied to activity patterns, and the detailed neurobiology of hunger and feeding as a motivated behavior. It examines the multifactorial control of food intake including oral/peripheral, gastric, and metabolic factors, body weight set points, and the influence of cognitive, cultural, and experiential factors on eating behavior.